About the Oncogenomics Researchers Session
Oncogenomics Researchers are scientists dedicated to exploring the genetic underpinnings of cancer. They focus on identifying genetic mutations, alterations, and expressions within cancer cells that contribute to tumor growth, metastasis, and resistance to treatment. By utilizing advanced techniques such as whole-genome sequencing, RNA sequencing, and bioinformatics tools, oncogenomics researchers examine the molecular landscape of cancer in unprecedented detail. Their work aims to uncover the specific genetic drivers of various cancers, leading to better-targeted therapies and more accurate diagnostic tools.
These researchers collaborate closely with oncologists, molecular biologists, and computational scientists to analyze vast amounts of genomic data and identify potential cancer biomarkers. By identifying genetic mutations that are common in certain cancers, oncogenomics researchers help develop targeted therapies that directly address the genetic alterations fueling tumor growth. This approach paves the way for precision medicine, where treatment plans are personalized to each patient's genetic profile, ensuring more effective treatments with fewer side effects. Oncogenomics researchers also contribute to clinical trials, testing new therapies based on genetic discoveries. Their efforts have already led to groundbreaking advances in cancer treatment, including targeted therapies and immunotherapies that have significantly improved patient outcomes. As the field of genomics continues to evolve, these researchers remain at the forefront of cancer research, driving the development of innovative treatments and offering hope for more effective, individualized cancer care.
Topics Covered in Oncogenomics Researchers
Whole-Genome Sequencing
RNA Sequencing
Mutational Signatures
Copy Number Alterations
Clonal Evolution
Pan-Cancer Analysis
Related Scientific Sessions at CIOC 2027
Why Attend the Oncogenomics Researchers Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Oncogenomics Researchers work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Oncogenomics Researchers research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Oncogenomics Researchers track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Oncogenomics Researchers Conference 2027 — FAQs
What is the Oncogenomics Researchers track at CIOC 2027?
The Oncogenomics Researchers track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Oncogenomics Researchers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Oncogenomics Researchers sessions?
Cancer researchers and clinicians, educators and students with an interest in Oncogenomics Researchers are all welcome — whether presenting or attending.
Can I present my research in the Oncogenomics Researchers track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Oncogenomics Researchers sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Oncogenomics Researchers track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.